MDL Sought For Generic Drug Valsartan Over Concerns Of Possible Carcinogen
WASHINGTON, D.C. — A plaintiff on Oct. 22 asked the Judicial Panel on Multidistrict Litigation (JPMDL) to centralize 11 federal valsartan product liability cases before Judge Freda L. Wolfson of the...To view the full article, register now.
Already a subscriber? Click here to view full article